Techsomed is a global medical imaging software company redefining precision in minimally invasive care. Its BioTraceIO360™ platform unifies CT, MRI, and ultrasound data into an intelligent clinical workflow powered by generative AI, enabling physicians to plan, predict, and validate treatments with unmatched clarity and control. From pre-procedure simulation to real-time tissue response prediction, Techsomed transforms guesswork into guidance – supporting safer, faster, and more consistent outcomes in image-guided therapy.
Tasso, Inc.
Tasso is a healthcare technology company transforming traditional blood collection with a patient-centric, virtually painless approach. Its devices enable simple, remote blood sampling for users and healthcare providers. Headquartered in Seattle, Washington, Tasso is privately held and supported through grants, investments, and partnerships with leading research and industry organizations. Learn more at www.tassoinc.com.
TAMASERV GmbH
TAMASERV is dedicated to advancing scientific research through developing and providing cutting-edge tools around RNA modifications. Our expertise lies in epitransriptomic solutions for RNA-based applications, supporting biotech and academics in unlocking new frontiers in molecular biology. With a strong commitment to precision and efficiency, we collaborate with partners around the globe to enhance RNA research and therapeutic developments. Expanding our vision, we have recently launched an ambitious crop yield improvement project. Leveraging our RNA modification expertise we are taking a dive into agricultural productivity and resilience. Recent high-profile research suggests that specific RNA modifications can serve as molecular predictors of crop resilience and yield. By integrating these insights with advanced analytics, we aim to develop novel strategies for improving agricultural products, particularly in regions with changing climate conditions. Partner with us in shaping the next generation of biotechnological advancements through unlocking the potential of RNA Modifications.
Takara Bio Inc.
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., is committed to helping scientists break new ground with innovative technologies for the life sciences. Our extensive portfolio of reagents, instruments, and services supports advancements across many areas of research, development, frontline diagnostics, and clinical applications. Our parent company, Takara Bio Inc., is a leading provider of biotechnology equipment and reagents, and conducts research and development activities involving gene- and cell-based therapies. Together with its subsidiaries, Takara Bio Inc. is committed to preventing disease and improving the quality of life for all through the use of biotechnology.
Taiwan Pavilion
Taiwan is located in the center of the Asia-Pacific region, with abundant medical resources, and diverse clusters of information and communication, semiconductor, and biomedical industries. It is suitable for the investment in development of precision health industries such as high-end medical materials, AI computing, and big data analysis. Taiwan medical device manufacturers have developed actively medical research and technology and we hope to cooperate with local industries, so it will be easier to enter the supply chain of major international brands. Metal Industries Research & Development Centre (MIRDC), a non-profit organization from Taiwan and assists Taiwan government to cultivate and reinforce the medical device industry in Taiwan. We also develop medical device products and technologies in industries including dental and orthopedic implants, devices, medical imaging, minimally invasive surgery instrument, and healthcare. | The biomedical industry is one of the six core strategic industries in Taiwan. It is an important power for Taiwan to play the leading role in global economy. With rich experiences of research, development and manufacturing, Taiwan excels in high-tech fields, clinical trials and biologics production. Continuing R&D support from government has created highly skilled workforce to innovate and advance the industry. Besides, Taiwan’s strategic location and grown-up supply chain make it an ideal partner for worldwide collaboration. There are more than 60 exhibitors and institutions in the Taiwan Pavilion this year, covering new drug development, CRO, CDMO, agriculture biotechnology, medical devices, precision medicine and smart health fields. Come and Join us to shape the future of precision health for all ages through collaboration and innovation with Taiwan’s thriving biomedical industry! | The biomedical industry is an important power for Taiwan to play the leading role in global economy. With rich experiences of research, development and manufacturing, Taiwan excels in high-tech fields, clinical trials and biologics production. Continuing R&D support from government has created highly skilled workforce to innovate and advance the industry. Besides, Taiwan’s strategic location and grown-up supply chain make it an ideal partner for worldwide collaboration. There are more than 60 exhibitors and institutions in the Taiwan Pavilion this year, covering new drug development, CRO, CDMO, agriculture biotechnology, medical devices, precision medicine and smart health fields. Come and Join us to shape the future of precision health for all ages through collaboration and innovation with Taiwan’s thriving biomedical industry! | BPIPO is honored to lead Taiwan’s delegation, featuring around 40 prominent companies and organizations specializing in new drug development, CDMO, regenerative medicine, agricultural biotechnology, precision medicine, and smart health. We warmly invite you to visit the Taiwan Pavilion and explore opportunities for collaboration. At our pavilion, you’ll discover not only innovative business partnerships but also insights into Taiwan’s supportive biomedical policies and unique research ecosystem. Taiwan has dedicated decades of effort to fostering a thriving biomedical industry, supported jointly by government initiatives and private sector innovation. This collaborative environment has successfully driven cross-domain growth and positioned Taiwan as a global biotechnology hub.
TaiHao Medical Inc
Taihao Medical designs and develops AI medical software to help healthcare providers manage the increasing workloads. We focus on breast screening & diagnostic solution by utilizing ultrasound and LDCT AI solutions for lung disease. Our leading products include: 1.BR-FHUSTM Smart System (Free-Hand ABUS): AI for ultrasound breast screening 2.BR-ViewerTM for ABUS 3.BU-CADTM Decision Support: AI for ultrasound breast cancer diagnosis 4.Ti–LUNGTM Decision Support: AI for LDCT lung cancer screening & diagnosis Leading technology & expertise include: 1.Real-Time AI detects suspicious areas in Ultrasound images 2.Advisory Board include scientists & physicians in Taiwan, Japan, China, and USA We have received US FDA, Japan’s PMDA, Taiwan’s TFDA, China’s NMPA, and more than 10 patent licenses. We not only advocate our products to the world, integrate with AI marketplace, but also cooperate with government’s screening program, women breast centers, mammography clinics, insurance companies and ultrasound machine manufacturers. Taihao Medical’s shareholders include CDIB Capital Healthcare Ventures Limited, Japan ＣＥＳデカルト, Top Taiwan Venture Capital Co., Ltd. and CTBC Securities Venture Capital Co., Ltd., who are involved in our capital investing. We strive for integrating our AI products in different types of ultrasound devices. Furthermore, global market expansion has been one of our key landmarks for the past and upcoming years, supported by our strong technical team in related areas. They are highly professional and well experienced. “Early Detection, Early Treatment, Most Lives Saved” is Taihao’s Value Proposition. We aim to be one of the most successful AI Medical companies worldwide. Welcome to follow our Linkedin and notice our continuous milestone, the latest news, and employees’ life in Taihao Medical.
SynOligo Biotechnologies
Headquartered in Morrisville, NC, USA, Synoligo Biotechnologies is a Contract Research and Development Organization (CRDO) specialized in manufacturing complex and highly modified oligonucleotide for academic, biotech start-up and large pharmaceutical communities. Synoligo is a leading oligonucleotide manufacturing company providing high quality, cost-effective custom oligonucleotides at varying scales for research, diagnostic, and therapeutic applications.
SYFM Co Ltd
We are equipped with the newest facilities to produce all kind of required items to produce our own unique products. Not only OEM, we can assure that we are expert on manufacturing products by ODM system with many years of experience to accomplish various requests from our customers.